No insider purchase over the last 90 days. The latest, by 李心一, was filed 05 May 2022.
Sinocare Inc.: what insiders have been doing
Sinocare Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Nothing new has been filed by managers of Sinocare Inc. in twelve months, the latest record being from 5 May 2022.
The full history, which starts in 2021, counts 3 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- +50.6%Entry CN¥18.17 · Close at T+365 CN¥27.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000 shares1.6% of flowA股XSHESZSE:173000005502939680Canonical exit: 3 Aug 2022 (T+90)
- 10,000 shares1.5% of flowA股XSHESZSE:173000005482413950Canonical exit: 27 Jul 2022 (T+90)
- 389,800 shares96.9% of flowA股XSHESZSE:173000005050533440Canonical exit: 6 Feb 2022 (T+90)
3 of 3 declarations
About Sinocare Inc.
三诺生物 is a company focused on the health and pharmaceutical sector, specializing in the development of diagnostic and treatment products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
